Acadia Pharmaceuticals (ACAD) Gross Margin (QoQ) (2016 - 2026)

Acadia Pharmaceuticals (ACAD) Gross Margin (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Acadia Pharmaceuticals 4.23 Bn 3.38 Bn 243.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.00
Dec 31, 2025 -147.00
Sep 30, 2025 7.00
Jun 30, 2025 51.00
Mar 31, 2025 5.00
Dec 31, 2024 -87.00
Sep 30, 2024 0.00
Jun 30, 2024 362.00
Mar 31, 2024 -341.00
Dec 31, 2023 -84.00
Sep 30, 2023 -239.00
Jun 30, 2023 -311.00
Mar 31, 2023 36.00
Dec 31, 2022 -13.00
Sep 30, 2022 35.00
Jun 30, 2022 57.00
Mar 31, 2022 566.00
Dec 31, 2021 -541.00
Sep 30, 2021 -61.00
Jun 30, 2021 -14.00